	Repurposing Anticancer Drugs in Parkinson's Treatment: Molecular Pathways Driving Neuroprotection and Therapeutic Advancement. Mol Neurobiol Bedage PL, Dhanush Y, Chettri P, Shivakumar, Ahmed SS, Raghunathanaidu BD. PMID: 42747624 [PubMed - indexed for MEDLINE]
	Correction: Ultrasonography demonstrates vagus nerve atrophy in Parkinson's disease: a meta-analysis. J Neurol Sijben LCJ, van Kuijk SMJ, Jahanshahi A, Mess WH, Janssen MLF. PMID: 42747571 [PubMed - in process]
	Changes in peripheral inflammatory cytokines and clinical outcomes before and after deep brain stimulation in patients with Parkinson's disease with or without type 2 diabetes mellitus: an observational study. Neurol Sci Cui C, Zuo D, Shen D, Xiao Q, Li J. PMID: 42747555 [PubMed - indexed for MEDLINE]
	Moving Beyond the Hyperkinetic Hypothesis for Weight Gain After Deep Brain Stimulation in Parkinson Disease. Neuromodulation Eisinger RS, Hamimi SA, Lee JM, Gabriel ED, Halpern CH. PMID: 42747368 [PubMed - as supplied by publisher]
	A Pilot Study Evaluating the Effect of Artesunate on Glymphatic-Related Fluid Transport in Parkinson's Disease Mouse Models InÂ Vivo and ExÂ Vivo. CNS Neurosci Ther Han WT, Lu WH, Xu H, Xie GH, Cao Y, Wu XY, Qiu F, Fu T. PMID: 42747247 [PubMed - indexed for MEDLINE]
	Awake or Asleep Subthalamic Deep Brain Stimulation for Parkinson's Disease: Further Research Is Needed. Neurosurgery Mikkelsen M, Sværke K, Fjeldhøj S, Rasmussen R, Bergdal O, Løkkegaard A. PMID: 42747167 [PubMed - as supplied by publisher]
	A neuron-distributed DEK integrates ac4C modification and neuroinflammation in pathogenesis of Parkinson disease: evidence from Mendelian randomization, multi-omics and in vitro validation. Front Neurosci Li Y. PMID: 42745872 [PubMed]
	Understanding Neuropsychiatric Fluctuations in Parkinson's Disease: From Mechanisms to Management. Mov Disord Clin Pract Sousa M, Amstutz D, Natera-Villalba E, Krack P, Martínez-Fernández R. PMID: 42745622 [PubMed - as supplied by publisher]
	Correction to "Randomized Observer-Blind Study on the Effects of Neuromuscolar Taping in Parkinson's Disease Patients". Mov Disord Clin Pract PMID: 42745511 [PubMed - as supplied by publisher]
	Emerging therapies expected to make a difference in Parkinson's disease management. Parkinsonism Relat Disord An AY, Kalia LV. PMID: 42744685 [PubMed - as supplied by publisher]
	EA-DualGAT: An error-aware dual-graph attention framework for Parkinson's disease diagnosis from wearable plantar pressure gait signals. Comput Biol Med Rashnu A, Salimi-Badr A. PMID: 42743854 [PubMed - as supplied by publisher]
	How Language Shapes Mechanistic Thinking in Parkinson Disease. Neurology Espay AJ, Lees AJ. PMID: 42743444 [PubMed - indexed for MEDLINE]
	Pharmacological modulation of cGAS-STING-NLRP3 signaling by nano-immunomodulators in Alzheimer and Parkinson disease. Inflammopharmacology Abdel-Rasol MA. PMID: 42742907 [PubMed - as supplied by publisher]
	Glutaric aciduria type 1 presenting with Parkinsonism with presynaptic dopaminergic dysfunction in an adult female: a case report. Neurogenetics Lokar M, Georgiev KJ, Rus T, Gregori, Peterlin B, Pu, Georgiev D. PMID: 42742749 [PubMed - indexed for MEDLINE]
	Sleep-Autonomic Interactions in Parkinson's Disease and Multiple System Atrophy: A Comparative Study Using Structural Equation Modeling. Mov Disord Clin Pract Jin B, Lee Y, Lee S, Yoon BA, Jeong YJ, Cheon SM. PMID: 42742667 [PubMed - as supplied by publisher]
	Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape. J Parkinsons Dis Antonini A, Gross RE, De Leon M, Kwok K, Foltynie T, Höglinger G, Gasser T, Corvol JC, Pedrosa DJ, Volkmann J, Henchcliffe C. PMID: 42742463 [PubMed - as supplied by publisher]
	Structural abnormalities in gray matter, white matter, and cerebrospinal fluid in parkinson's disease: a voxel-based morphometry study. Neurol Res Shi Y, Zhang Y, Zhang Y, Wu Y, Liu X, Feng K, Cheng Y, Yin S. PMID: 42742255 [PubMed - as supplied by publisher]
	Short-term heart rate variability is preserved in Parkinson's disease under atomoxetine. Brain Commun Orlando IF, Hezemans FH, Tsvetanov KA, Ye R, Rua C, Regenthal R, Barker RA, Williams-Gray CH, Passamonti L, Robbins TW, Rowe JB, O'Callaghan C. PMID: 42741788 [PubMed]
	Real-world deep brain stimulation programming practices for Parkinson's disease in India: variability, technology adoption, and emerging trends from a multicentre clinician survey across India. Front Neurol Pal PK, Rajan R, Krishnan Nair S, Yadav R, Anand M, Balakrishnan S, Baldia M, Banarjee AD, Borgohain R, Ganguly J, Ginjupally DR, Holla VV, Hosurkar G, Kamble N, Kandadai RM, Kayal A, Kohat AK, Kumar H, Mahale RR, Matur V, Prasad S, Shiva Kumar R, Sheikh A, Shetty K, Singh S, Venkatachalam A, Shankar V, Vysakh KV, Yareeda S. PMID: 42741162 [PubMed - indexed for MEDLINE]
	LRRK2: Molecular Mechanisms in Parkinson's Disease. Int J Mol Sci Arias-Carrión O, Guerra-Crespo M, Ortuño-Sahagún D, Ortega-Robles E. PMID: 42737506 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 58852

Page 1 of 2943



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy